Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

A Toll-like receptor 2 genetic variant modulates occurrence of bacterial infections in patients with sickle cell disease.

Tozatto-Maio K, Girot R, Ly ID, Rocha V, Silva Pinto AC, Diagne I, Benzerara Y, Dinardo CL, Kashima S, Leston-Araujo I, Kenzey C, Fonseca GHH, Rodrigues ES, Volt F, Jarduli LR, Ruggeri A, Mariaselvam CM, Gualandro SFM, Elayoubi H, Cunha R, Cappelli B, Malmegrim KCR, Simões BP, Gluckman E, Tamouza R.

Br J Haematol. 2019 Jun;185(5):918-924. doi: 10.1111/bjh.15875. Epub 2019 Mar 25.

PMID:
30908604
2.

Multicentre randomised controlled trial to investigate usefulness of the rapid diagnostic βLACTA test performed directly on bacterial cell pellets from respiratory, urinary or blood samples for the early de-escalation of carbapenems in septic intensive care unit patients: the BLUE-CarbA protocol.

Garnier M, Gallah S, Vimont S, Benzerara Y, Labbe V, Constant AL, Siami S, Guerot E, Compain F, Mainardi JL, Montil M, Quesnel C; BLUE-CarbA study group.

BMJ Open. 2019 Feb 19;9(2):e024561. doi: 10.1136/bmjopen-2018-024561.

3.

Daily Green Tea Infusions in Hypercalciuric Renal Stone Patients: No Evidence for Increased Stone Risk Factors or Oxalate-Dependent Stones.

Rode J, Bazin D, Dessombz A, Benzerara Y, Letavernier E, Tabibzadeh N, Hoznek A, Tligui M, Traxer O, Daudon M, Haymann JP.

Nutrients. 2019 Jan 24;11(2). pii: E256. doi: 10.3390/nu11020256.

4.

Renin-angiotensin system blockade promotes a cardio-renal protection in albuminuric homozygous sickle cell patients.

Haymann JP, Hammoudi N, Stankovic Stojanovic K, Galacteros F, Habibi A, Avellino V, Bartolucci P, Benzerara Y, Arlet JB, Djebbar M, Letavernier E, Grateau G, Tabibzadeh N, Girshovich A, Chaignon M, Girot R, Levy P, Lionnet F.

Br J Haematol. 2017 Dec;179(5):820-828. doi: 10.1111/bjh.14969. Epub 2017 Oct 19.

PMID:
29048108
5.

Emergence of Plasmid-Mediated Fosfomycin-Resistance Genes among Escherichia coli Isolates, France.

Benzerara Y, Gallah S, Hommeril B, Genel N, Decré D, Rottman M, Arlet G.

Emerg Infect Dis. 2017 Sep;23(9):1564-1567. doi: 10.3201/eid2309.170560.

6.

β LACTA test performance for detection of extended-spectrum β-lactamase-producing Gram-negative bacilli directly on bronchial aspirates samples: a validation study.

Gallah S, Benzerara Y, Tankovic J, Woerther PL, Bensekri H, Mainardi JL, Arlet G, Vimont S, Garnier M.

Clin Microbiol Infect. 2018 Apr;24(4):402-408. doi: 10.1016/j.cmi.2017.07.030. Epub 2017 Aug 3.

7.

Emergence of DHA-1-producing Klebsiella spp. in the Parisian region: genetic organization of the ampC and ampR genes originating from Morganella morganii.

Verdet C, Benzerara Y, Gautier V, Adam O, Ould-Hocine Z, Arlet G.

Antimicrob Agents Chemother. 2006 Feb;50(2):607-17.

8.

Selection during cefepime treatment of a new cephalosporinase variant with extended-spectrum resistance to cefepime in an Enterobacter aerogenes clinical isolate.

Barnaud G, Benzerara Y, Gravisse J, Raskine L, Sanson-Le Pors MJ, Labia R, Arlet G.

Antimicrob Agents Chemother. 2004 Mar;48(3):1040-2.

9.
10.

BUT-1: a new member in the chromosomal inducible class C beta-lactamases family from a clinical isolate of Buttiauxella sp.

Fihman V, Rottman M, Benzerara Y, Delisle F, Labia R, Philippon A, Arlet G.

FEMS Microbiol Lett. 2002 Jul 16;213(1):103-11.

11.

Supplemental Content

Loading ...
Support Center